Difference between revisions of "Normative:COVID-19"
(new addition) |
|||
| Line 1: | Line 1: | ||
==Normative== | ==Normative== | ||
=== | === Synonyms and variants === | ||
=== | * covid19 | ||
=== Definition === | |||
COVID-19 is a multisystem disease which, in certain cases, will require full multidisciplinary team rehabilitation to enable recovery (208). | |||
<small>Source: [https://apps.who.int/iris/bitstream/handle/10665/338882/WHO-2019-nCoV-clinical-2021.1-eng.pd https://apps.who.int/iris/bitstream/handle/10665/338882/WHO-2019-nCoV-clinical-2021.1-eng.pdf]</small> | |||
=== Encyclopaedic information === | === Encyclopaedic information === | ||
Source: | Emerging evidence suggests that excess mortality due to COVID-19 is higher in black, Asian and minority ethnic groups. | ||
<small>Source: https://www.nice.org.uk/guidance/ng191/resources/covid19-rapid-guideline-managing-covid19-pdf-51035553326</small> | |||
Furthermore, the majority of long-term care service users are older people with multiple underlying conditions and weak immune systems, which make them more susceptible to severe COVID-19 and poor outcomes (245). | |||
<small>Source: [https://apps.who.int/iris/bitstream/handle/10665/338882/WHO-2019-nCoV-clinical-2021.1-eng.pd https://apps.who.int/iris/bitstream/handle/10665/338882/WHO-2019-nCoV-clinical-2021.1-eng.pdf]</small> | |||
=== Examples === | |||
<blockquote>Identifying bacterial co-infection or superinfection in patients with '''COVID-19''' is challenging, as the symptoms may be similar to those of the underlying viral infection.</blockquote><small>Source: https://www.sccm.org/getattachment/Disaster/SSC-COVID19-Critical-Care-Guidelines.pdf</small><blockquote>Because clinical information about the optimal management of '''COVID-19''' is evolving quickly, these Guidelines will be updated frequently as published data and other authoritative information become available.</blockquote><small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small><blockquote>When starting treatment for '''COVID-19''' in patients with HIV, clinicians should pay careful attention to potential drug-drug interactions and overlapping toxicities among '''COVID-19''' treatments, ARV medications, antimicrobial therapies, and other medications (AIII).</blockquote><small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small> | |||
===Collocations=== | ===Collocations=== | ||
* moderate covid-19 | |||
* severe covid-19 | |||
* covid-19 vaccine | |||
* | * | ||
===Keyness=== | ===Keyness=== | ||
* covid-19: 13 | |||
===Note=== | ===Note=== | ||
Latest revision as of 12:58, 8 February 2022
Normative
Synonyms and variants
- covid19
Definition
COVID-19 is a multisystem disease which, in certain cases, will require full multidisciplinary team rehabilitation to enable recovery (208).
Source: https://apps.who.int/iris/bitstream/handle/10665/338882/WHO-2019-nCoV-clinical-2021.1-eng.pdf
Encyclopaedic information
Emerging evidence suggests that excess mortality due to COVID-19 is higher in black, Asian and minority ethnic groups.
Furthermore, the majority of long-term care service users are older people with multiple underlying conditions and weak immune systems, which make them more susceptible to severe COVID-19 and poor outcomes (245).
Source: https://apps.who.int/iris/bitstream/handle/10665/338882/WHO-2019-nCoV-clinical-2021.1-eng.pdf
Examples
Identifying bacterial co-infection or superinfection in patients with COVID-19 is challenging, as the symptoms may be similar to those of the underlying viral infection.
Source: https://www.sccm.org/getattachment/Disaster/SSC-COVID19-Critical-Care-Guidelines.pdf
Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines will be updated frequently as published data and other authoritative information become available.
Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
When starting treatment for COVID-19 in patients with HIV, clinicians should pay careful attention to potential drug-drug interactions and overlapping toxicities among COVID-19 treatments, ARV medications, antimicrobial therapies, and other medications (AIII).
Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
Collocations
- moderate covid-19
- severe covid-19
- covid-19 vaccine
Keyness
- covid-19: 13